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Public health systems have generally been based on an essentially 
biological model, with actions taking place in a fragmented way. These 
systems were founded on medical knowledge, which has focused on 
pathologies rather than on health status.
At present, public health urgently requires the inclusion of the 
social determinants of health and the deep conjunctural and structural 
transformations that extend across contemporary societies. Some of these 
transformations are associated with demographic changes such as a fall of 
the fertility rate and decreased infant mortality, coupled with an increase 
in life expectancy. These characteristics have substantially modified the 
structure of the population pyramid, incorporating demographic changes 
that have a direct impact on public health at a global scale, as a result of 
the increase in chronic noncommunicable diseases and the presence of 
chronic co-morbidities. The epidemiological profile is also affected; in 
the Americas an increasing prevalence of chronic-degenerative diseases 
has been observed, in addition to the infectious diseases already present 
in the region.1
Science and technological development have advanced rapidly, 
incorporating new discoveries and paradigm shifts into curative and 
preventive medical care. These advances include bio-drugs, robotics, nano-
devices, therapeutic vaccines, individualized treatments, among others. 
Genomics is a relevant area of the present and future of medicine. It is 
responsible for many of the abovementioned advances. Genomics is aimed 
at a predictive, personalized and preventive medicine. However, as in many 
other medical fields, access to genomics is unequal and determined by the 
patients’ socioeconomic background. This is a challenge for the current 
health systems, in terms of improving the availability of these advances to 
the entire population.
Over the past decades, there has been increasing interest in the study of 
genetic predispositions to complex diseases. This interest has materialized 
in a large amount of epidemiological publications on associations between 
gene and disease. However, the magnitude of the association between a 
given genotype and a given condition has not always been determined. 
Given the above, it is necessary to identify the true genetic associations 
between the presence of a complex disease and the underlying genotype. 
Authors such as Khoury et al.,2 point out that the synthesis of knowledge 
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is crucial to the integration of evidence-based genomics 
and public health in the 21st century.
The use of informatics and databases contributes to 
improving the monitoring and follow-up of patients and 
their pathologies in the field of genetics. This monitoring 
corresponds to the systematic and continuous collection, 
analysis and interpretation of the data to guide actions 
in public health. At present, big data allows for the 
identification of patterns for early detection of infectious 
or chronic diseases. Big data also allows the monitoring 
of population movements and potentially infected 
individuals, as for example, in the case of Ebola in Africa. 
The latter was possible thanks to the use of mobile phones 
to track in real time the movement of people who may be 
infected and thus prevent future outbreaks.3
In this context, it is necessary to implement sufficiently 
strong computer networks to achieve good connectivity 
and interoperability of clinical, laboratory and public 
health systems. In addition, the storage and use of genetic 
and non-genetic information for research and development 
must consider bioethical aspects such as privacy, protection 
of genomic data and informed consent.
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